Genentech Inc.

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) () Cossarizza A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, et al. Journal article The IL-22-oncostatin M axis promotes intestinal inflammation and tumorigenesis (2025) Cineus R, Luo Y, Saliutina M, Manna S, Cancino CA, Velasco Blázquez L, Wang L, et al. Journal article Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study (2023) Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, et al. Journal article Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer (2023) Denkert C, Lambertini C, Fasching P, Pogue-Geile KL, Mano MS, Untch M, Wolmark N, et al. Journal article Towards Giving Timely Formative Feedback and Hints to Novice Programmers (2022) Jeuring J, Keuning H, Marwan S, Bouvier D, Izu C, Kiesler N, Lehtinen T, et al. Conference contribution Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response (2022) Slob EMA, Faiz A, Van Nijnatten J, Vijverberg SJH, Longo C, Kutlu M, Chew FT, et al. Journal article Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways (2022) Aliee H, Massip F, Qi C, Stella De Biase M, Van Nijnatten J, Kersten ETG, Kermani NZ, et al. Journal article Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial (2022) Sandborn WJ, Panés J, Danese S, Sharafali Z, Hassanali A, Jacob-Moffatt R, Eden C, et al. Journal article The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments (2021) Grieshaber-Bouyer R, Radtke FA, Cunin P, Stifano G, Levescot A, Nelson-Maney N, Blaustein RB, et al. Journal article New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension (2021) Stone JH, Spotswood H, Unizony SH, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Journal article